{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:15:24Z","timestamp":1788480924391,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16359-7","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:48:22Z","timestamp":1782146902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of tumor-infiltrating lymphocytes across breast cancer stages at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia"],"prefix":"10.1186","volume":"26","author":[{"given":"Emiyamrew","family":"Getnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashaw","family":"Adane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrem","family":"Awoke Shiferaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadele","family":"Ayelegn Nibret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gebremariam","family":"Maru Yemru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyahl Kassye","family":"Mengstu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe","family":"Birhanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afewerk","family":"Habtamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtu","family":"Debash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadelo","family":"Wondmagegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem","family":"Lemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"3","key":"16359_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"1","key":"16359_CR2","doi-asserted-by":"publisher","first-page":"7048","DOI":"10.1038\/s41598-022-10560-x","volume":"12","author":"L Ilic","year":"2022","unstructured":"Ilic L, et al. Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983\u20132017). Sci Rep. 2022;12(1):7048.","journal-title":"Sci Rep"},{"issue":"5","key":"16359_CR3","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.31557\/APJCP.2022.23.5.1603","volume":"23","author":"A Chokoev","year":"2022","unstructured":"Chokoev A, et al. Breast cancer incidence in Kyrgyzstan: Report of 15 years of cancer registry. Asian Pac J cancer prevention: APJCP. 2022;23(5):1603.","journal-title":"Asian Pac J cancer prevention: APJCP"},{"issue":"8","key":"16359_CR4","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/ijc.33014","volume":"147","author":"WY Joko-Fru","year":"2020","unstructured":"Joko-Fru WY, et al. The evolving epidemic of breast cancer in sub\u2010Saharan Africa: Results from the African Cancer Registry Network. Int J Cancer. 2020;147(8):2131\u201341.","journal-title":"Int J Cancer"},{"issue":"1","key":"16359_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12905-022-01672-7","volume":"22","author":"W Ayele","year":"2022","unstructured":"Ayele W, et al. Breast cancer morbidity and mortality in rural Ethiopia: data from 788 verbal autopsies. BMC Womens Health. 2022;22(1):89.","journal-title":"BMC Womens Health"},{"issue":"8","key":"16359_CR6","doi-asserted-by":"publisher","first-page":"e0271895","DOI":"10.1371\/journal.pone.0271895","volume":"17","author":"M Aynalem","year":"2022","unstructured":"Aynalem M, et al. Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center. PLoS ONE. 2022;17(8):e0271895.","journal-title":"PLoS ONE"},{"issue":"1","key":"16359_CR7","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1186\/s12885-020-07654-y","volume":"20","author":"Z-h Gao","year":"2020","unstructured":"Gao Z-h, et al. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis. BMC Cancer. 2020;20(1):1150.","journal-title":"BMC Cancer"},{"key":"16359_CR8","doi-asserted-by":"publisher","first-page":"610303","DOI":"10.3389\/fonc.2021.610303","volume":"11","author":"V Salemme","year":"2021","unstructured":"Salemme V, et al. The crosstalk between tumor cells and the immune microenvironment in breast cancer: implications for immunotherapy. Front Oncol. 2021;11:610303.","journal-title":"Front Oncol"},{"issue":"8","key":"16359_CR9","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1073\/pnas.1104303108","volume":"109","author":"B Ruffell","year":"2012","unstructured":"Ruffell B, et al. Leukocyte composition of human breast cancer. Proc Natl Acad Sci. 2012;109(8):2796\u2013801.","journal-title":"Proc Natl Acad Sci"},{"issue":"15","key":"16359_CR10","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SM Mahmoud","year":"2011","unstructured":"Mahmoud SM, et al. Tumor-infiltrating CD8\u2009+\u2009lymphocytes predict clinical outcome in breast cancer. J Clin Oncol. 2011;29(15):1949\u201355.","journal-title":"J Clin Oncol"},{"issue":"2","key":"16359_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, et al. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26(2):259\u201371.","journal-title":"Ann Oncol"},{"issue":"1","key":"16359_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40\u201350.","journal-title":"Lancet Oncol"},{"issue":"3","key":"16359_CR13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.4161\/onci.18614","volume":"1","author":"S Mahmoud","year":"2012","unstructured":"Mahmoud S, et al. CD8\u2009+\u2009T lymphocytes infiltrating breast cancer: a promising new prognostic marker? Oncoimmunology. 2012;1(3):364\u20135.","journal-title":"Oncoimmunology"},{"key":"16359_CR14","doi-asserted-by":"crossref","unstructured":"Ciarka A et al. Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes. Biomedicines, 2024;12(4):763-76.","DOI":"10.3390\/biomedicines12040763"},{"key":"16359_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-016-0165-6","volume":"4","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Disis ML. Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J Immunother Cancer. 2016;4:1\u20137.","journal-title":"J Immunother Cancer"},{"issue":"19","key":"16359_CR16","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.3390\/cancers15194771","volume":"15","author":"M Zareinejad","year":"2023","unstructured":"Zareinejad M, et al. Dual functions of T lymphocytes in breast carcinoma: from immune protection to orchestrating tumor progression and metastasis. Cancers. 2023;15(19):4771.","journal-title":"Cancers"},{"issue":"7","key":"16359_CR17","first-page":"2445","volume":"29","author":"R Matkowski","year":"2009","unstructured":"Matkowski R, et al. The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res. 2009;29(7):2445\u201351.","journal-title":"Anticancer Res"},{"key":"16359_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1590\/S1807-59322006000300004","volume":"61","author":"AH Macchetti","year":"2006","unstructured":"Macchetti AH, et al. Tumor-infiltrating CD4\u2009+\u2009T lymphocytes in early breast cancer reflect lymph node involvement. Clinics. 2006;61:203\u20138.","journal-title":"Clinics"},{"issue":"10","key":"16359_CR19","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","volume":"2","author":"SE Stanton","year":"2016","unstructured":"Stanton SE, Adams S, Disis ML. Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review. JAMA Oncol. 2016;2(10):1354\u201360.","journal-title":"JAMA Oncol"},{"issue":"1","key":"16359_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13058-020-01267-w","volume":"22","author":"M Kim","year":"2020","unstructured":"Kim M, et al. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast. Breast Cancer Res. 2020;22(1):32.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"16359_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3233\/BD-200442","volume":"39","author":"M Pujani","year":"2020","unstructured":"Pujani M, et al. Evaluation of Tumor infiltrating lymphocytes in breast carcinoma and their correlation with molecular subtypes, tumor grade and stage. Breast Dis. 2020;39(2):61\u20139.","journal-title":"Breast Dis"},{"issue":"8","key":"16359_CR22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/jnci\/djaa215","volume":"113","author":"S Yao","year":"2021","unstructured":"Yao S, et al. Breast tumor microenvironment in black women: a distinct signature of CD8\u2009+\u2009T-cell exhaustion. JNCI: J Natl Cancer Inst. 2021;113(8):1036\u201343.","journal-title":"JNCI: J Natl Cancer Inst"},{"issue":"7","key":"16359_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1158\/1055-9965.EPI-21-1312","volume":"31","author":"AM Hamilton","year":"2022","unstructured":"Hamilton AM, et al. The landscape of immune microenvironments in racially diverse breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2022;31(7):1341\u201350.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"16359_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-020-01297-4","volume":"22","author":"Y Abdou","year":"2020","unstructured":"Abdou Y, et al. Racial differences in CD8\u2009+\u2009T cell infiltration in breast tumors from Black and White women. Breast Cancer Res. 2020;22:1\u201310.","journal-title":"Breast Cancer Res"},{"key":"16359_CR25","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fonc.2020.01022","volume":"10","author":"G Kim","year":"2020","unstructured":"Kim G, et al. The contribution of race to breast tumor microenvironment composition and disease progression. Front Oncol. 2020;10:1022.","journal-title":"Front Oncol"},{"issue":"3","key":"16359_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.4274\/ejbh.galenos.2021.2021-4-3","volume":"17","author":"H Zhu","year":"2021","unstructured":"Zhu H, Do\u011fan BE. American Joint Committee on Cancer\u2019s Staging System for Breast Cancer, Eighth Edition: Summary for Clinicians. Eur J Breast Health. 2021;17(3):234\u20138.","journal-title":"Eur J Breast Health"},{"issue":"15","key":"16359_CR27","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.3390\/app11156788","volume":"11","author":"G Angelico","year":"2021","unstructured":"Angelico G, et al. Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer. Appl Sci. 2021;11(15):6788.","journal-title":"Appl Sci"},{"issue":"1","key":"16359_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.33371\/ijoc.v19i1.1164","volume":"19","author":"R Damayanti","year":"2025","unstructured":"Damayanti R, et al. Relationship Between Tumor Infiltrating Lymphocytes (TIL) With Histopathological Grading, Tumor Size, and Axillary Lymph Node Metastases in Breast Cancer at the Anatomical Pathology Laboratory of Soedarso Hospital Pontianak. Indonesian J Cancer. 2025;19(1):9\u201317.","journal-title":"Indonesian J Cancer"},{"issue":"18","key":"16359_CR29","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.3390\/cancers15184479","volume":"15","author":"G Angelico","year":"2023","unstructured":"Angelico G, et al. Tumor infiltrating lymphocytes (TILS) and PD-L1 expression in breast cancer: A review of current evidence and prognostic implications from pathologist\u2019s perspective. Cancers. 2023;15(18):4479.","journal-title":"Cancers"},{"issue":"7","key":"16359_CR30","doi-asserted-by":"publisher","first-page":"BSR20201054","DOI":"10.1042\/BSR20201054","volume":"40","author":"J Fang","year":"2020","unstructured":"Fang J, et al. Prognostic value of immune checkpoint molecules in breast cancer. Biosci Rep. 2020;40(7):BSR20201054.","journal-title":"Biosci Rep"},{"issue":"6","key":"16359_CR31","first-page":"1081","volume":"4","author":"AA Kibret","year":"2023","unstructured":"Kibret AA, et al. University of Gondar Comprehensive Specialized Hospital: A Retrospective Follow up Study. Health. 2023;4(6):1081.","journal-title":"Health"},{"issue":"7","key":"16359_CR32","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/cncr.23319","volume":"112","author":"M Morrogh","year":"2008","unstructured":"Morrogh M, et al. Changing indications for surgery in patients with stage IV breast cancer: a current perspective. Cancer. 2008;112(7):1445\u201354.","journal-title":"Cancer"},{"issue":"15","key":"16359_CR33","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-17-3509","volume":"24","author":"D Tamborero","year":"2018","unstructured":"Tamborero D, et al. A pan-cancer landscape of interactions between solid tumors and infiltrating immune cell populations. Clin Cancer Res. 2018;24(15):3717\u201328.","journal-title":"Clin Cancer Res"},{"key":"16359_CR34","doi-asserted-by":"crossref","unstructured":"Br\u00eenza D et al. Expression of CD8, CD68 and HER2 markers in breast carcinoma in diabetes patients. Archives Balkan Med Union, 2025: pp. 509\u201318.","DOI":"10.31688\/ABMU.2025.60.4.07"},{"issue":"49","key":"16359_CR35","doi-asserted-by":"publisher","first-page":"e5602","DOI":"10.1097\/MD.0000000000005602","volume":"95","author":"X-B Zhao","year":"2016","unstructured":"Zhao X-B, Ren G-S. Diabetes mellitus and prognosis in women with breast cancer: a systematic review and meta-analysis. Medicine. 2016;95(49):e5602.","journal-title":"Medicine"},{"issue":"1","key":"16359_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1186\/s12885-019-5828-5","volume":"19","author":"K Takada","year":"2019","unstructured":"Takada K, et al. Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer. BMC Cancer. 2019;19(1):615.","journal-title":"BMC Cancer"},{"issue":"1","key":"16359_CR37","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1038\/s41467-025-59408-8","volume":"16","author":"M Bauer","year":"2025","unstructured":"Bauer M, et al. HIV status alters immune cell infiltration and activation profile in women with breast cancer. Nat Commun. 2025;16(1):4699.","journal-title":"Nat Commun"},{"issue":"5","key":"16359_CR38","doi-asserted-by":"publisher","first-page":"e64225","DOI":"10.1371\/journal.pone.0064225","volume":"8","author":"RM Jeselsohn","year":"2013","unstructured":"Jeselsohn RM, et al. Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS ONE. 2013;8(5):e64225.","journal-title":"PLoS ONE"},{"key":"16359_CR39","unstructured":"TILs working group. training for TILs count.; Available from: https:\/\/www.tilsinbreastcancer.org\/"},{"issue":"1","key":"16359_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41523-020-0156-0","volume":"6","author":"Z Kos","year":"2020","unstructured":"Kos Z, et al. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. NPJ breast cancer. 2020;6(1):17.","journal-title":"NPJ breast cancer"},{"issue":"3","key":"16359_CR41","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.sapharm.2012.04.004","volume":"9","author":"N Gisev","year":"2013","unstructured":"Gisev N, Bell JS, Chen TF. Interrater agreement and interrater reliability: key concepts, approaches, and applications. Res Social Administrative Pharm. 2013;9(3):330\u20138.","journal-title":"Res Social Administrative Pharm"},{"issue":"1","key":"16359_CR42","first-page":"159174","volume":"33","author":"G Landis JRKoch","year":"1977","unstructured":"Landis JRKoch G. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159174.","journal-title":"Biometrics"},{"issue":"7","key":"16359_CR43","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1245\/s10434-016-5173-8","volume":"23","author":"SK Swisher","year":"2016","unstructured":"Swisher SK, et al. Interobserver agreement between pathologists assessing tumor-infiltrating lymphocytes (TILs) in breast cancer using methodology proposed by the International TILs Working Group. Ann Surg Oncol. 2016;23(7):2242\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"16359_CR44","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"P Schober","year":"2018","unstructured":"Schober P, Boer C, Schwarte LA. Correlation Coefficients: Appropriate Use and Interpretation. Anesth Analgesia. 2018;126(5):1763\u20138.","journal-title":"Anesth Analgesia"},{"issue":"3","key":"16359_CR45","first-page":"361","volume":"140","author":"AS Rathore","year":"2014","unstructured":"Rathore AS, et al. CD3+, CD4+ & CD8\u2009+\u2009tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast. Indian J Med Res. 2014;140(3):361\u20139.","journal-title":"Indian J Med Res"},{"key":"16359_CR46","first-page":"1409","volume":"3","author":"A Bhatia","year":"2018","unstructured":"Bhatia A, Kumar Y. Tumour infiltrating lymphocytes: Changing trends. Clin Oncol. 2018;3:1409.","journal-title":"Clin Oncol"},{"issue":"continuous publ","key":"16359_CR47","first-page":"pA008","volume":"21","author":"PR Martins","year":"2025","unstructured":"Martins PR, Jacauna A, Buzzelin C. Clinical, histopathological, and immunological profiles of luminal invasive breast carcinoma in different stages. Brazilian J Oncol. 2025;21(continuous publication):pA008.","journal-title":"Brazilian J Oncol"},{"issue":"2","key":"16359_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0377-4929.118676","volume":"56","author":"TE Helal","year":"2013","unstructured":"Helal TE, Ibrahim EA, Alloub AI. Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: relation to prognostic variables. Indian J Pathol Microbiol. 2013;56(2):89\u201393.","journal-title":"Indian J Pathol Microbiol"},{"key":"16359_CR49","doi-asserted-by":"publisher","unstructured":"Kolarov-Bjelobrk I et al. Clinical relevance of determination of tumour infiltrating lymphocytes in breast carcinoma. West Indian Med J. 2017. https:\/\/doi.org\/10.7727\/WIMJ.2017.044.","DOI":"10.7727\/WIMJ.2017.044"},{"issue":"8","key":"16359_CR50","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1093\/annonc\/mdu112","volume":"25","author":"S Loi","year":"2014","unstructured":"Loi S, et al. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. Ann Oncol. 2014;25(8):1544\u201350.","journal-title":"Ann Oncol"},{"issue":"13","key":"16359_CR51","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1001\/jama.2024.3056","volume":"331","author":"RA Leon-Ferre","year":"2024","unstructured":"Leon-Ferre RA, et al. Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. JAMA. 2024;331(13):1135\u201344.","journal-title":"JAMA"},{"issue":"1","key":"16359_CR52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41523-021-00346-1","volume":"7","author":"K El Bairi","year":"2021","unstructured":"El Bairi K, et al. The tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group. NPJ breast cancer. 2021;7(1):150.","journal-title":"NPJ breast cancer"},{"key":"16359_CR53","doi-asserted-by":"publisher","first-page":"1250189","DOI":"10.3389\/fendo.2023.1250189","volume":"14","author":"EB Belachew","year":"2023","unstructured":"Belachew EB, et al. Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia. Front Endocrinol. 2023;14:1250189.","journal-title":"Front Endocrinol"},{"issue":"3","key":"16359_CR54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-022-06769-z","volume":"196","author":"Z Desalegn","year":"2022","unstructured":"Desalegn Z, et al. Intrinsic subtypes in Ethiopian breast cancer patient. Breast Cancer Res Treat. 2022;196(3):495\u2013504.","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"16359_CR55","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","volume":"172","author":"F Mor","year":"2004","unstructured":"Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol. 2004;172(7):4618\u201323.","journal-title":"J Immunol"},{"issue":"1","key":"16359_CR56","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s12885-020-07101-y","volume":"20","author":"K Takada","year":"2020","unstructured":"Takada K, et al. Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer. BMC Cancer. 2020;20(1):598.","journal-title":"BMC Cancer"},{"issue":"4","key":"16359_CR57","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota SJ, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. Embo j. 2001;20(4):672\u201382.","journal-title":"Embo j"},{"key":"16359_CR58","unstructured":"Fares M et al. The impact of tumor-infiltrating lymphocytes on tumor features and pathological characteristics in breast cancer patients: the role of cytotoxic T lymphocytes and regulatory T cells. Eur Rev Med Pharmacol Sci. 2022;26(12): 4207\u20134219."},{"issue":"10","key":"16359_CR59","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1242\/jcs.02334","volume":"118","author":"CH Stuelten","year":"2005","unstructured":"Stuelten CH, et al. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-\u03b1 and TGF-\u03b2. J Cell Sci. 2005;118(10):2143\u201353.","journal-title":"J Cell Sci"},{"issue":"8","key":"16359_CR60","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.4049\/jimmunol.171.8.4340","volume":"171","author":"JL Owen","year":"2003","unstructured":"Owen JL, et al. Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor. J Immunol. 2003;171(8):4340\u201351.","journal-title":"J Immunol"},{"key":"16359_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","volume":"27","author":"D Mittal","year":"2014","unstructured":"Mittal D, et al. New insights into cancer immunoediting and its three component phases\u2014elimination, equilibrium and escape. Curr Opin Immunol. 2014;27:16\u201325.","journal-title":"Curr Opin Immunol"},{"key":"16359_CR62","doi-asserted-by":"crossref","unstructured":"Chen B et al. Immunotherapy of Cancer by Targeting Regulatory T cells. Authorea Preprints, 2024.","DOI":"10.22541\/au.170667889.96637484\/v1"},{"issue":"2","key":"16359_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/BF02305798","volume":"3","author":"BJ Camp","year":"1996","unstructured":"Camp BJ, et al. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann Surg Oncol. 1996;3(2):176\u201384.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"16359_CR64","first-page":"16","volume":"5","author":"M Kumar","year":"2023","unstructured":"Kumar M, et al. Correlation of tumor-infiltrating lymphocytes with tumor staging and grading in breast carcinomas: a retrospective study. Int J Sci Res Dent Med Sci. 2023;5(1):16\u201320.","journal-title":"Int J Sci Res Dent Med Sci"},{"key":"16359_CR65","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ejca.2019.12.003","volume":"127","author":"L de Boo","year":"2020","unstructured":"de Boo L, et al. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. Eur J Cancer. 2020;127:240\u201350.","journal-title":"Eur J Cancer"},{"key":"16359_CR66","doi-asserted-by":"publisher","first-page":"e2300715","DOI":"10.1200\/PO.23.00715","volume":"8","author":"RB Wyatt Castillo","year":"2024","unstructured":"Wyatt Castillo RB, et al. Disparate rates of germline variants in cancer predisposition genes in African American\/Black compared with non-Hispanic White individuals between 2015 and 2022. JCO Precision Oncol. 2024;8:e2300715.","journal-title":"JCO Precision Oncol"},{"issue":"1","key":"16359_CR67","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13058-020-01297-4","volume":"22","author":"Y Abdou","year":"2020","unstructured":"Abdou Y, et al. Racial differences in CD8\u2009+\u2009T cell infiltration in breast tumors from Black and White women. Breast Cancer Res. 2020;22(1):62.","journal-title":"Breast Cancer Res"},{"issue":"11","key":"16359_CR68","doi-asserted-by":"publisher","first-page":"e0224760","DOI":"10.1371\/journal.pone.0224760","volume":"14","author":"A Mremi","year":"2019","unstructured":"Mremi A, et al. Breast cancer in Tanzanian, black American, and white American women: An assessment of prognostic and predictive features, including tumor infiltrating lymphocytes. PLoS ONE. 2019;14(11):e0224760.","journal-title":"PLoS ONE"},{"issue":"7","key":"16359_CR69","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/1097-0142(19820401)49:7<1456::AID-CNCR2820490724>3.0.CO;2-#","volume":"49","author":"I Shimokawara","year":"1982","unstructured":"Shimokawara I, et al. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: An immunoperoxidase study with anti-human T\u2010and B\u2010cell sera. Cancer. 1982;49(7):1456\u201364.","journal-title":"Cancer"},{"key":"16359_CR70","doi-asserted-by":"publisher","first-page":"794175","DOI":"10.3389\/fimmu.2022.794175","volume":"13","author":"H Locy","year":"2022","unstructured":"Locy H, et al. Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring. Front Immunol. 2022;13:794175.","journal-title":"Front Immunol"},{"issue":"2","key":"16359_CR71","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3126\/jpn.v12i2.47200","volume":"12","author":"S Karki","year":"2022","unstructured":"Karki S, Tiwari SB, Basnet A. Evaluation of tumor infiltrating lymphocytes in breast carcinomas. J Pathol Nepal. 2022;12(2):1909\u201312.","journal-title":"J Pathol Nepal"},{"issue":"2","key":"16359_CR72","first-page":"87","volume":"28","author":"N.J Patil","year":"2026","unstructured":"Patil N.J., et al. Assessment of Tumor Infiltrating Lymphocytes in Breast Cancer Patients and its Correlation with Clinico-Histopathological Characteristics and Molecular Subtypes. JK Science: J Med Educ Res. 2026;28(2):87\u201391.","journal-title":"JK Science: J Med Educ Res"},{"issue":"7","key":"16359_CR73","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.31557\/APJCP.2023.24.7.2523","volume":"24","author":"TT Duong","year":"2023","unstructured":"Duong TT, et al. Stromal tumor-infiltrating lymphocytes associated with immunohistopathology and molecular subtypes of breast cancer in Vietnam. Asian Pac J cancer prevention: APJCP. 2023;24(7):2523.","journal-title":"Asian Pac J cancer prevention: APJCP"},{"issue":"1","key":"16359_CR74","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12967-016-0983-9","volume":"14","author":"M Miyan","year":"2016","unstructured":"Miyan M, et al. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer. J Transl Med. 2016;14(1):227.","journal-title":"J Transl Med"},{"key":"16359_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41182-017-0059-4","volume":"45","author":"RT Sawe","year":"2017","unstructured":"Sawe RT, et al. Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya. Trop Med Health. 2017;45:19.","journal-title":"Trop Med Health"},{"issue":"7","key":"16359_CR76","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/jnci\/djx268","volume":"110","author":"C Desmedt","year":"2018","unstructured":"Desmedt C, et al. Immune Infiltration in Invasive Lobular Breast Cancer. J Natl Cancer Inst. 2018;110(7):768\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"16359_CR77","doi-asserted-by":"publisher","unstructured":"Verma P et al. Comparative Analysis of Stromal Tumor Infiltrating Lymphocytes in Various Grades and Molecular Subtypes of Breast Carcinoma. Ann Afr Med, 9900: p. https:\/\/doi.org\/10.4103\/aam.aam_873_25","DOI":"10.4103\/aam.aam_873_25"},{"issue":"10","key":"16359_CR78","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/modpathol.2016.109","volume":"29","author":"C Denkert","year":"2016","unstructured":"Denkert C, et al. Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Mod Pathol. 2016;29(10):1155\u201364.","journal-title":"Mod Pathol"},{"issue":"1","key":"16359_CR79","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/0284186X.2017.1403040","volume":"57","author":"T Tramm","year":"2018","unstructured":"Tramm T, et al. Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists. Acta Oncol. 2018;57(1):90\u20134.","journal-title":"Acta Oncol"},{"key":"16359_CR80","doi-asserted-by":"publisher","first-page":"95","DOI":"10.25259\/Cytojournal_116_2025","volume":"22","author":"M Sughayer","year":"2025","unstructured":"Sughayer M, et al. Interobserver concordance of tumor-infiltrating lymphocyte assessment in triple-negative breast carcinoma; tissue microarray versus whole sections. CytoJournal. 2025;22:95.","journal-title":"CytoJournal"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16359-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16359-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:02:55Z","timestamp":1788480175000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16359-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16359"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16359-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from the Ethical Review Committee of the School of Biomedical and Laboratory Sciences at the College of Medicine and Health Sciences, University of Gondar, under reference number SBMLS\/784, dated 13 June 2024. Participant recruitment, clinical data collection, and specimen handling were conducted from 20 June 2024 to 19 June 2025. A letter of permission was obtained from the UOG-CSH clinical director. Informed consent was obtained from all study participants, and patient confidentiality was maintained by assigning unique codes and removing personal identifiers, such as names, throughout the study. This study was conducted in accordance with the ethical standards laid down in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1049"}}